
New findings suggest semaglutide's benefits may extend well beyond diabetes and weight loss and into airway disease and mood disorders.
NEW YORK (Reuters Health) - Low-dose aspirin is predominantly of value in reducing atherosclerotic events in patients with less advanced diabetes, Japanese researchers report in an April 22nd online paper in Diabetes Care.






